EP 1052980 A1 20001122 - SUBCUTANEOUS MEDROXYPROGESTERONE ACETATE FOR TREATMENT OF MENOPAUSE AND ENDOMETRIOSIS
Title (en)
SUBCUTANEOUS MEDROXYPROGESTERONE ACETATE FOR TREATMENT OF MENOPAUSE AND ENDOMETRIOSIS
Title (de)
SUBKUTANE VERABREICHUNG VON MEDROXYPROGESTERONACETAT ZUR BEHANDLUNG VON KLIMAKTERISCHER BESCHWERDEN UND ENDOMETRIOSE
Title (fr)
ACETATE DE MEDROXYPROGESTERONE ADMINISTRE PAR VOIE SOUS-CUTANEE EN VUE DU TRAITEMENT DE LA MENOPAUSE ET DE L'ENDOMETRIOSE
Publication
Application
Priority
- US 9920904 W 19991006
- US 10369998 P 19981009
- US 12682499 P 19990330
Abstract (en)
[origin: WO0021511A2] One aspect of the present invention is a method of human female menopause treatment which comprises subcutaneous administration of a menopausely effective amount of a hormonal replacement agent selected from the group consisting of a progestogen and a progestogen plus an estrogen. Another aspect of the present invention is treating endometriosis.
IPC 1-7
IPC 8 full level
A61K 31/565 (2006.01); A61K 31/567 (2006.01); A61K 31/57 (2006.01); A61P 5/30 (2006.01); A61P 5/34 (2006.01); A61P 15/00 (2006.01); A61P 15/12 (2006.01); A61P 15/18 (2006.01); C07J 7/00 (2006.01)
CPC (source: EP)
A61K 31/57 (2013.01); A61P 5/30 (2017.12); A61P 5/34 (2017.12); A61P 15/00 (2017.12); A61P 15/12 (2017.12); A61P 15/18 (2017.12)
Citation (search report)
See references of WO 0021511A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0021511 A2 20000420; WO 0021511 A3 20001130; AU 1197100 A 20000501; BR 9906862 A 20011127; CA 2311937 A1 20000420; EP 1052980 A1 20001122; JP 2002527380 A 20020827
DOCDB simple family (application)
US 9920904 W 19991006; AU 1197100 A 19991006; BR 9906862 A 19991006; CA 2311937 A 19991006; EP 99970317 A 19991006; JP 2000575487 A 19991006